JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data
- 21 January 2024
- Vol. 42 (3) , 548-555
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May–July 2022Vaccine, 2023
- Defining and emulating target trials of the effects of postexposure vaccination using observational datamedRxiv, 2023
- Breakthrough Infections after Postexposure Vaccination against MpoxNew England Journal of Medicine, 2022
- Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022Eurosurveillance, 2022
- Monkeypox outbreak in the Netherlands in 2022: public health response, epidemiological and clinical characteristics of the first 1000 cases and protection of the first-generation smallpox vaccinemedRxiv, 2022
- Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against SmallpoxNew England Journal of Medicine, 2019
- Assessment of the Protective Effect of Imvamune and Acam2000 Vaccines against Aerosolized Monkeypox Virus in Cynomolgus MacaquesJournal of Virology, 2013
- Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virusProceedings of the National Academy of Sciences, 2008
- Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protectionJournal of Clinical Investigation, 2008
- THE 1972 SMALLPOX OUTBREAK IN KHULNA MUNICIPALITY, BANGLADESH: II. EFFECTIVENESS OF SURVEILLANCE AND CONTAINMENT IN URBAN EPIDEMIC CONTROL1American Journal of Epidemiology, 1974